Dr Reddy’s Laboratories (RDY) has released an update.
Dr. Reddy’s Laboratories successfully concluded its 40th AGM, held virtually on July 29, 2024, where all resolutions presented were passed, including the adoption of financial statements and the declaration of a Rs. 40 per share dividend. Key discussions included financial performance clarifications and the re-appointment of Mr. K Satish Reddy as a Director. The event marked a transparent voting process, facilitated through remote e-voting and an e-voting session during the AGM.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
